News & Events
Page 1 of 1
"The first major opioid trial starts today" by Sarah Owermohle and Sarah Karlin-Smith
Rob Smith was quoted in Politico's Prescription Pulse on May 28, 2019.
The article reads:
The Community Oncology Alliance is pushing an alternative on Capitol Hill that would replace the current average sales price plus six percent reimbursement rate for Part B drugs with a tiered system. Providers would get a higher percentage add-on for lower-cost drugs, and a lower percentage add-on for higher-cost drugs, Rob Smith of Capital Alpha Partners wrote in a note to clients.
Although the community oncologists carry a lot of weight on the Hill, Smith writes, he doesn’t think its proposal would serve as a complete alternative to the IPI structure, since it doesn’t directly address drug prices, take on Trump’s concerns regarding higher U.S. prices or inject more competition and negotiation into Part B.